SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A fair growth of 14.83% in the revenue at Rs. 14677.03 millions was reported in the March 2026 quarter as compared to Rs. 12781.88 millions during year-ago period.Net profit surges 67.46% to Rs. 2336.97  millions  from Rs. 1395.57 millions in the quarter ended March 2026.The company reported a good operating profit of 3985.94 millions compared to 2670.33 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 14677.03 12781.88 14.83 52431.88 43819.24 19.65 52431.88 43819.24 19.65
Other Income 269.39 223.96 20.28 2095.16 1188.07 76.35 2095.16 1188.07 76.35
PBIDT 3985.94 2670.33 49.27 13342.66 7656.44 74.27 13342.66 7656.44 74.27
Interest 368.67 240.69 53.17 1182.71 1129.62 4.70 1182.71 1129.62 4.70
PBDT 3693.06 2429.64 52.00 11909.24 6526.82 82.47 11909.24 6526.82 82.47
Depreciation 630.40 569.12 10.77 2467.33 2249.72 9.67 2467.33 2249.72 9.67
PBT 3062.66 1860.52 64.61 9441.91 4277.10 120.75 9441.91 4277.10 120.75
TAX 725.69 464.95 56.08 2112.32 1105.82 91.02 2112.32 1105.82 91.02
Deferred Tax -62.93 -170.95 -63.19 -225.09 -21.25 959.25 -225.09 -21.25 959.25
PAT 2336.97 1395.57 67.46 7329.59 3171.28 131.12 7329.59 3171.28 131.12
Equity 1895.90 1894.83 0.06 1895.90 1894.83 0.06 1895.90 1894.83 0.06
PBIDTM(%) 27.16 20.89 29.99 25.45 17.47 45.64 25.45 17.47 45.64

Emcure Pharma Share Price

1663.70 3.70 (0.22%)
07-May-2026 14:57 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1836.60
Dr. Reddys Lab 1311.90
Cipla 1369.40
Zydus Lifesciences 941.85
Lupin 2457.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×